CN101561432A - 一种能够维护酶标记物溶液高稳定性的稀释液 - Google Patents
一种能够维护酶标记物溶液高稳定性的稀释液 Download PDFInfo
- Publication number
- CN101561432A CN101561432A CNA2009101436375A CN200910143637A CN101561432A CN 101561432 A CN101561432 A CN 101561432A CN A2009101436375 A CNA2009101436375 A CN A2009101436375A CN 200910143637 A CN200910143637 A CN 200910143637A CN 101561432 A CN101561432 A CN 101561432A
- Authority
- CN
- China
- Prior art keywords
- dilution
- solution
- enzyme labeling
- mass percent
- labeling thing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 63
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 63
- 238000010790 dilution Methods 0.000 title claims abstract description 55
- 239000012895 dilution Substances 0.000 title claims abstract description 55
- 239000000243 solution Substances 0.000 title claims abstract description 51
- 239000003550 marker Substances 0.000 title abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 28
- 239000007853 buffer solution Substances 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 239000000654 additive Substances 0.000 claims abstract description 11
- 230000000996 additive effect Effects 0.000 claims abstract description 11
- 238000002372 labelling Methods 0.000 claims description 49
- 210000002966 serum Anatomy 0.000 claims description 25
- 230000002421 anti-septic effect Effects 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 13
- 238000013016 damping Methods 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 11
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 10
- JCZPMGDSEAFWDY-SQOUGZDYSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide Chemical compound NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO JCZPMGDSEAFWDY-SQOUGZDYSA-N 0.000 claims description 9
- 239000004475 Arginine Substances 0.000 claims description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 9
- 239000004472 Lysine Substances 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 9
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 9
- 229960005480 sodium caprylate Drugs 0.000 claims description 9
- BYKRNSHANADUFY-UHFFFAOYSA-M sodium octanoate Chemical compound [Na+].CCCCCCCC([O-])=O BYKRNSHANADUFY-UHFFFAOYSA-M 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 229960003487 xylose Drugs 0.000 claims description 9
- 241001116389 Aloe Species 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 8
- 235000011399 aloe vera Nutrition 0.000 claims description 8
- 239000000427 antigen Substances 0.000 claims description 8
- 108091007433 antigens Proteins 0.000 claims description 8
- 102000036639 antigens Human genes 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 244000309466 calf Species 0.000 claims description 7
- 241000700721 Hepatitis B virus Species 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- -1 compound amino acid Chemical class 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 3
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 3
- 229930182566 Gentamicin Natural products 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 241001494479 Pecora Species 0.000 claims description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 3
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000004833 fish glue Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 229960002518 gentamicin Drugs 0.000 claims description 3
- 208000002672 hepatitis B Diseases 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 abstract description 10
- 238000000034 method Methods 0.000 abstract description 6
- 150000001413 amino acids Chemical class 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 4
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 abstract description 4
- 238000000338 in vitro Methods 0.000 abstract 3
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 230000003197 catalytic effect Effects 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 108010006591 Apoenzymes Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000002337 glycosamines Chemical class 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- CPUHNROBVJNNPW-UHFFFAOYSA-N aloin A Natural products OC1C(O)C(O)C(CO)OC1OC1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 CPUHNROBVJNNPW-UHFFFAOYSA-N 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
天数 | 0 | 3 | 4 | 5 | 6 | 7 |
稀释液(1) | 53268 | 26129 | 15980 | 8013 | 2674 | 1065 |
稀释液(2) | 54162 | 54067 | 53762 | 51457 | 48516 | 45811 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101436375A CN101561432B (zh) | 2009-05-27 | 2009-05-27 | 一种能够维护酶标记物溶液高稳定性的稀释液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101436375A CN101561432B (zh) | 2009-05-27 | 2009-05-27 | 一种能够维护酶标记物溶液高稳定性的稀释液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101561432A true CN101561432A (zh) | 2009-10-21 |
CN101561432B CN101561432B (zh) | 2012-08-01 |
Family
ID=41220323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101436375A Active CN101561432B (zh) | 2009-05-27 | 2009-05-27 | 一种能够维护酶标记物溶液高稳定性的稀释液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101561432B (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102051352B (zh) * | 2009-11-02 | 2012-07-04 | 刘萍 | 一种酶结合物稳定液 |
CN102866248A (zh) * | 2012-09-28 | 2013-01-09 | 北京鸿天志远科技有限公司 | 稳定剂溶液及其制备方法,酶结合物混合液和蛋白质混合液 |
CN102879567A (zh) * | 2012-09-29 | 2013-01-16 | 同昕生物技术(北京)有限公司 | 用于肝癌诊断的甲胎蛋白异质体分离试剂盒及其组成试剂与应用 |
CN103091306A (zh) * | 2013-01-23 | 2013-05-08 | 苏州浩欧博生物医药有限公司 | 一种纳米磁微粒的封闭保存液 |
CN104698189A (zh) * | 2015-03-12 | 2015-06-10 | 北京中航赛维生物科技有限公司 | 保护异硫氰酸荧光素与抗原抗体偶联物的稳定剂及其制备方法和用途 |
CN106526164A (zh) * | 2016-10-27 | 2017-03-22 | 河南省医药科学研究院 | 一种酶标记抗体应用稀释液及其制备方法 |
CN106771133A (zh) * | 2016-11-30 | 2017-05-31 | 三诺生物传感股份有限公司 | 一种组合物及其作为酶标复合物保存液的应用 |
CN107037207A (zh) * | 2017-06-20 | 2017-08-11 | 山东莱博生物科技有限公司 | 一种丙肝抗体多聚体酶标记物及其制备与应用 |
CN107037217A (zh) * | 2016-11-16 | 2017-08-11 | 广州华弘生物科技有限公司 | 脂蛋白a的酶联免疫试剂盒及其制备方法 |
CN107400164A (zh) * | 2017-07-18 | 2017-11-28 | 中山和芯生物技术有限公司 | 一种含蔗糖的生物制品稳定剂及其制备方法和应用 |
CN108663511A (zh) * | 2018-05-25 | 2018-10-16 | 苏州佑君环境科技有限公司 | 一种碱性磷酸酶抗原抗体专用稀释液 |
CN109212180A (zh) * | 2018-10-19 | 2019-01-15 | 广东菲鹏生物有限公司 | 用于小分子抗原与碱性磷酸酶标记结合物的保存液及其制备方法 |
CN109444439A (zh) * | 2018-11-14 | 2019-03-08 | 宁波瑞源生物科技有限公司 | 一种稳定的液体型凝血酶时间测定试剂盒 |
CN109444438A (zh) * | 2018-10-25 | 2019-03-08 | 宁波瑞源生物科技有限公司 | 一种用于aptt检测试剂的稳定剂及aptt检测试剂 |
CN111024959A (zh) * | 2019-12-20 | 2020-04-17 | 深圳市蔚景生物科技有限公司 | 一种稳定的蛋白质溶液、其制备方法及检测试剂盒 |
CN112979810A (zh) * | 2019-12-16 | 2021-06-18 | 广东菲鹏生物有限公司 | Tag-72抗体-hrp稀释液及其应用 |
CN113567661A (zh) * | 2021-07-05 | 2021-10-29 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | 一种酶标抗体保护液 |
CN114200125A (zh) * | 2021-12-06 | 2022-03-18 | 武汉生之源生物科技股份有限公司 | 一种不含蛋白的碱性磷酸酶-抗体偶联物稀释液及其制备方法 |
CN114397460A (zh) * | 2021-12-09 | 2022-04-26 | 华南理工大学 | 生物标记物的保存液以及生物标记物试剂 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018133038A1 (zh) | 2017-01-20 | 2018-07-26 | 深圳市新产业生物医学工程股份有限公司 | 标记复合物及其制备方法、试剂盒、应用和检测系统 |
-
2009
- 2009-05-27 CN CN2009101436375A patent/CN101561432B/zh active Active
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102051352B (zh) * | 2009-11-02 | 2012-07-04 | 刘萍 | 一种酶结合物稳定液 |
CN102866248A (zh) * | 2012-09-28 | 2013-01-09 | 北京鸿天志远科技有限公司 | 稳定剂溶液及其制备方法,酶结合物混合液和蛋白质混合液 |
CN102879567B (zh) * | 2012-09-29 | 2014-11-05 | 同昕生物技术(北京)有限公司 | 用于肝癌诊断的甲胎蛋白异质体分离试剂盒及其组成试剂与应用 |
CN102879567A (zh) * | 2012-09-29 | 2013-01-16 | 同昕生物技术(北京)有限公司 | 用于肝癌诊断的甲胎蛋白异质体分离试剂盒及其组成试剂与应用 |
CN103091306B (zh) * | 2013-01-23 | 2015-07-01 | 苏州浩欧博生物医药有限公司 | 一种纳米磁微粒的封闭保存液 |
CN103091306A (zh) * | 2013-01-23 | 2013-05-08 | 苏州浩欧博生物医药有限公司 | 一种纳米磁微粒的封闭保存液 |
CN104698189A (zh) * | 2015-03-12 | 2015-06-10 | 北京中航赛维生物科技有限公司 | 保护异硫氰酸荧光素与抗原抗体偶联物的稳定剂及其制备方法和用途 |
CN106526164A (zh) * | 2016-10-27 | 2017-03-22 | 河南省医药科学研究院 | 一种酶标记抗体应用稀释液及其制备方法 |
CN106526164B (zh) * | 2016-10-27 | 2018-05-29 | 河南省医药科学研究院 | 一种酶标记抗体应用稀释液及其制备方法 |
CN107037217A (zh) * | 2016-11-16 | 2017-08-11 | 广州华弘生物科技有限公司 | 脂蛋白a的酶联免疫试剂盒及其制备方法 |
CN106771133A (zh) * | 2016-11-30 | 2017-05-31 | 三诺生物传感股份有限公司 | 一种组合物及其作为酶标复合物保存液的应用 |
CN107037207A (zh) * | 2017-06-20 | 2017-08-11 | 山东莱博生物科技有限公司 | 一种丙肝抗体多聚体酶标记物及其制备与应用 |
CN107400164A (zh) * | 2017-07-18 | 2017-11-28 | 中山和芯生物技术有限公司 | 一种含蔗糖的生物制品稳定剂及其制备方法和应用 |
CN108663511A (zh) * | 2018-05-25 | 2018-10-16 | 苏州佑君环境科技有限公司 | 一种碱性磷酸酶抗原抗体专用稀释液 |
CN109212180A (zh) * | 2018-10-19 | 2019-01-15 | 广东菲鹏生物有限公司 | 用于小分子抗原与碱性磷酸酶标记结合物的保存液及其制备方法 |
CN109212180B (zh) * | 2018-10-19 | 2021-10-12 | 广东菲鹏生物有限公司 | 用于小分子抗原与碱性磷酸酶标记结合物的保存液及其制备方法 |
CN109444438B (zh) * | 2018-10-25 | 2022-03-15 | 宁波瑞源生物科技有限公司 | 一种用于aptt检测试剂的稳定剂及aptt检测试剂 |
CN109444438A (zh) * | 2018-10-25 | 2019-03-08 | 宁波瑞源生物科技有限公司 | 一种用于aptt检测试剂的稳定剂及aptt检测试剂 |
CN109444439B (zh) * | 2018-11-14 | 2022-03-15 | 宁波瑞源生物科技有限公司 | 一种稳定的液体型凝血酶时间测定试剂盒 |
CN109444439A (zh) * | 2018-11-14 | 2019-03-08 | 宁波瑞源生物科技有限公司 | 一种稳定的液体型凝血酶时间测定试剂盒 |
CN112979810A (zh) * | 2019-12-16 | 2021-06-18 | 广东菲鹏生物有限公司 | Tag-72抗体-hrp稀释液及其应用 |
CN112979810B (zh) * | 2019-12-16 | 2023-03-14 | 广东菲鹏生物有限公司 | Tag-72抗体-hrp稀释液及其应用 |
CN111024959A (zh) * | 2019-12-20 | 2020-04-17 | 深圳市蔚景生物科技有限公司 | 一种稳定的蛋白质溶液、其制备方法及检测试剂盒 |
CN113567661A (zh) * | 2021-07-05 | 2021-10-29 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | 一种酶标抗体保护液 |
CN113567661B (zh) * | 2021-07-05 | 2024-04-16 | 深圳市计量质量检测研究院(国家高新技术计量站、国家数字电子产品质量监督检验中心) | 一种酶标抗体保护液 |
CN114200125A (zh) * | 2021-12-06 | 2022-03-18 | 武汉生之源生物科技股份有限公司 | 一种不含蛋白的碱性磷酸酶-抗体偶联物稀释液及其制备方法 |
CN114200125B (zh) * | 2021-12-06 | 2024-02-13 | 武汉生之源生物科技股份有限公司 | 一种不含蛋白的碱性磷酸酶-抗体偶联物稀释液及其制备方法 |
CN114397460A (zh) * | 2021-12-09 | 2022-04-26 | 华南理工大学 | 生物标记物的保存液以及生物标记物试剂 |
CN114397460B (zh) * | 2021-12-09 | 2022-11-11 | 华南理工大学 | 生物标记物的保存液以及生物标记物试剂 |
Also Published As
Publication number | Publication date |
---|---|
CN101561432B (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101561432B (zh) | 一种能够维护酶标记物溶液高稳定性的稀释液 | |
CN101949944B (zh) | 三碘甲状腺原氨酸定量检测试剂盒 | |
CN101256188B (zh) | 检测林可霉素药物的酶联免疫试剂盒及其应用 | |
CN101949942B (zh) | 游离三碘甲状腺原氨酸定量检测试剂盒 | |
CN101413943B (zh) | 一种检测三聚氰胺的方法及其专用酶联免疫试剂盒 | |
CN102955031A (zh) | 检测黄曲霉毒素b1药物的酶联免疫试剂盒及其应用 | |
CN101949943A (zh) | 促甲状腺激素定量检测试剂盒及其制备方法 | |
CN102967709A (zh) | 检测玉米赤霉烯酮药物的酶联免疫试剂盒及其应用 | |
CN101315378B (zh) | 检测硝基咪唑类药物的方法及其专用酶联免疫试剂盒 | |
CN101571542B (zh) | 一种检测齐帕特罗的直接竞争法酶联免疫试剂盒 | |
CN102226808A (zh) | 胰蛋白酶原-2化学发光免疫检测试剂盒及其制备方法 | |
CN101358967B (zh) | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 | |
CN101403752A (zh) | 一种加替沙星的化学发光酶联免疫检测试剂盒 | |
CN101377496A (zh) | 一种检测甲状腺过氧化物酶自身抗体的化学发光免疫分析测定试剂盒 | |
CN102565399B (zh) | 一种检测氢化可的松的方法及其专用酶联免疫试剂盒 | |
ZA200600150B (en) | Reagents, methods and kits for detecting feed enzymes | |
CN102943066B (zh) | 一种人载脂蛋白b100单克隆抗体及其化学发光免疫分析测定试剂盒 | |
CN103197077A (zh) | 一种检测微量牛免疫球蛋白g的试剂盒 | |
CN101561439A (zh) | 一种呋喃妥因残留酶联免疫检测试剂盒 | |
CN103018447A (zh) | 检测沙丁胺醇的酶联免疫试剂盒及其方法 | |
CN101315377B (zh) | 一种检测莫能菌素的方法及其专用酶联免疫试剂盒 | |
CN103102319A (zh) | 三聚氰胺半抗原及其制备方法和应用 | |
Landry | Developments in immunologic assays for respiratory viruses | |
CN101556284B (zh) | 甲型肝炎病毒抗原检测方法 | |
CN101571549B (zh) | Vero细胞HCP检测试剂盒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20091021 Assignee: BEIJING YUANCHENG KEYI BIOLOGICAL TECHNOLOGY CO.,LTD. Assignor: FUJIAN HONGCHENG BIOLOG MEDICI Contract record no.: 2014990000722 Denomination of invention: Dilution being capable of maintaining high stability of enzyme marker solution Granted publication date: 20120801 License type: Exclusive License Record date: 20140828 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Dilution being capable of maintaining high stability of enzyme marker solution Effective date of registration: 20170601 Granted publication date: 20120801 Pledgee: China Everbright Bank Limited by Share Ltd. Fuzhou branch Pledgor: FUJIAN HONGCHENG BIOLOG MEDICI Registration number: 2017350000068 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20191023 Granted publication date: 20120801 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20221023 Granted publication date: 20120801 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20221023 Granted publication date: 20120801 |